Key points for investors:
- Strategy & priorities: Management is focused on three priorities — increasing cash flow, intensifying cost improvements, and driving top-line growth via the Engineered Materials (EM) pipeline and high‑impact programs.
- 2026 earnings outlook: CEO Scott Richardson said Celanese can grow EPS by $1 to $2 in 2026 even in a flattish demand environment, driven roughly half by cost actions and the remainder largely from EM pipeline/product wins (with some contribution from interest expense reduction).
- Cost savings & free cash flow: Management expects additional cost savings (EM targeted $30–50M and other enterprise actions) and CFO Chuck Kyrish expects interest expense to fall ~$30–40M year‑over‑year. Free cash flow guidance is sustainable at the low end of $700–$800M going forward; working capital was a $250M cash source in 2025 but is not expected to repeat at that magnitude in 2026.
- Portfolio actions / divestitures: Celanese remains active on portfolio simplification and committed to $1 billion of divestitures by end of 2027. The Micromax sale (announced) takes them about halfway to that goal; tax leakage on such sales is expected to be about 5% of gross proceeds.
- Asset & plant actions: The Lanaken acetate tow plant will close (highest‑cost asset) producing ~$20–30M productivity savings in 2027 (a partial benefit late 2026). Management continues to evaluate footprint/complexity reductions where value creation exists.
- Acetyls and network operations: Lowest‑cost acetyl assets are being run at full rates; other assets are flexed to match demand. Singapore and Frankfurt have been operated in blocks; Singapore is being flexed and Frankfurt is offline for the rest of the year.
- Pricing & demand: EM volumes were down ~8% year‑over‑year, concentrated in higher‑volume standard grade thermoplastics (POM, nylon, polyesters). EM pricing improved (best in ~8 quarters) and management expects more commercial pricing and mix opportunities. China acetyl pricing has stabilized and showed a small lift into October; Europe saw some downstream price pressure tied to weaker demand.
- Goodwill impairment: An impairment was recorded in Q3 for EM goodwill/intangibles; management says this was driven by a lower market capitalization (stock price decline) rather than a reduction in projected cash flows.
- Balance sheet / maturities: Management is comfortable addressing near‑term debt maturities with free cash flow, divestiture proceeds, and liquidity, while remaining opportunistic in the debt markets to smooth timing mismatches.
Sign In
Buy CE
